Pharmacokinetics of intramuscular piroxicam
Public Interest Statement
Copmarative pharmacokinetics of intramuscular sulphadimidine in non-starved and starved male and female grower turkeys. Metabolism of piroxicam by laboratory animals. Thus, the results of this study confirm the minimal systemic absorption of piroxicam during multiple-dose application of the 0.
The pharmacokinetics of Hemiscorpius lepturus scorpion venom and Razi antivenom following intramuscular administration in rat. But in female goats, there was plasma concentration of The samples were mixed and the optical density of the resulting color determined at nm wavelength using a spectrophotometer.
The samples were allowed to stand for 2 min before adding 0. Source for synthesis of central nervous system acting drugs. Discussion The pharmacokinetic profiles of intramuscular piroxicam in male and female WAD goats fit two compartment open model Figure 1.
There are considerable within-species and inter-species variations in half-life which are likely to be due in part, to the method applied in the corresponding investigations [ 54 ].
As the concentration of the drug increases, the number of water molecules to dissolve it decreases. Comparative pharmacokinetics of piroxicam in male and female West African Dwarf goats.
July 31, Citation: Studies of percutaneous absorption and tissue distribution of piroxicam gel.
Search the history of over billion web pages on the Internet. Journal of Experimental Neuroscience10— Funding The research was funded by the authors. The correlation coefficient R2 was greater than 0. Sulphadimidine has been documented to be more rapidly eliminated after injection faster than oral sulphadimidine mixed with feed or drinking water [ 60 ]. But the value of elimination rate constant 0. Contributor Korean Society of Applied Pharmacology. Pharmacokinetics of oxicam non-steroidal anti-inflammatory agents.
Also a single administration of piroxicam may be sufficient to relieve pain, reduce swelling and decrease high body temperature for a number of days, invariably reducing cost of treatment in WAD goats. Piroxicam can reside in the body of WAD goats for upto 8 days; this may pose risk of tissue residues to consumers of such meat. Pharmacokinetics of piroxicam, a new nonsteroidal anti-inflammatory agent, under fasting and post prandial states in man.